Abstract 836: Immunologic markers and the progression of liver disease in HCV-positive individuals
Sign Up to like & getrecommendations! Published in 2021 at "Epidemiology"
DOI: 10.1158/1538-7445.am2021-836
Abstract: Background: Host immune response and chronic inflammation associated with chronic hepatitis C virus (HCV) infection play a key role in the progression of liver disease from cirrhosis to hepatocellular carcinoma (HCC). We evaluated a large… read more here.
Keywords: progression liver; disease hcv; immunologic markers; markers progression ... See more keywords
Integrated Genomic and Transcriptomic Analyses of Diffuse Large B-Cell Lymphoma With Multiple Abnormal Immunologic Markers
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.790720
Abstract: Background Diffuse large B-cell lymphoma (DLBCL) is a highly aggressive subtype of lymphoma and related to autoimmune diseases (AIDs). Primary B-cell receptor-mediated AIDs are associated with poor clinical outcome of DLBCL. To further determine the… read more here.
Keywords: cell; lymphoma; multiple abnormal; immunologic markers ... See more keywords
Association between Immunologic Markers and Cirrhosis in Individuals from a Prospective Chronic Hepatitis C Cohort
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14215280
Abstract: Simple Summary To date: no prospective cohort studies have been used to investigate the role of circulating immunologic markers as they relate to the progression of liver disease in those chronically infected with hepatitis C… read more here.
Keywords: individuals developed; hepatitis; cohort; cirrhosis ... See more keywords